EMEA-000387-PIP01-08

  • Email
  • Help

Overview

Product details for Lantus
Invented nameLantus
Active substance

Insulin glargine

Decision numberP/133/2009
PIP numberEMEA-000387-PIP01-08
Pharmaceutical form(s)Solution for injection, Solution for injection in a vial, Solution for injection in a cartridge
Condition(s)/indication(s)

Diabetes mellitus

Route(s) of administrationSubcutaneous use
PIP applicant

Applicant: Sanofi-Aventis Deutschland GmbH
E-mail: sylvie.gabriel@sanofi-aventis.com
Country: France
Phone: + 33 153774152
Fax: 33 153774133

Decision typeP: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) and or deferral(s)
Compliance check procedure numberEMEA-C-000387-PIP01-08
Compliance check opinion date18/11/2011
Compliance check outcomePositive

Decision

Related information